Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04565925 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment closed, study ongoing
    • Site details revised at 2 of 2 sites
    v18
  2. Minor Re-verified, no change to tracked fieldsv17
  3. Notable Primary and study completion dates: Dec 1, 2025 to Dec 1, 2026v16
  4. Notable Primary and study completion dates: Dec 1, 2024 to Dec 1, 2025v15
  5. Notable Primary and study completion dates: Dec 1, 2023 to Dec 1, 2024v14
Show 12 earlier versionsHide 12 earlier versions
  1. Minor Re-verified, no change to tracked fieldsv13
  2. Minor Site details revised at 1 of 2 sitesv12
  3. Minor Start date changed from estimate of Aug 25, 2021 to Jul 7, 2021v11
  4. Notable Start date: Jul 25, 2021 to Aug 25, 2021v10
  5. Notable Start date: Jun 25, 2021 to Jul 25, 2021
    • Site contacts updated at 1 of 2 sites
    v9
  6. Minor Start date: Jun 10, 2021 to Jun 25, 2021v8
  7. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: May 1, 2021 to Jun 10, 2021
    • Site details revised at 2 of 2 sites
    v7
  8. Notable Primary and study completion dates: Dec 1, 2022 to Dec 1, 2023
    • Start date: Mar 1, 2021 to May 1, 2021
    • Study sites: 1 to 2
    v6
  9. Minor Start date: Feb 1, 2021 to Mar 1, 2021v5
  10. Notable Start date: Jan 1, 2021 to Feb 1, 2021v4
  11. Notable Start date: Nov 1, 2020 to Jan 1, 2021v3
  12. Minor Secondary endpoints revised (18)
    • Study description expanded, about 6 words
    • Eligibility criteria expanded, about 1 word
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to determine whether administration of sildenafil will decrease urine leakage in patients with spinal cord injuries.
Trial Details
NCT Number NCT04565925
Lead Sponsor The University of Texas Medical Branch, Galveston
Conditions
(from sponsor)
Spinal Cord Injuries, Urinary Incontinence
Related terms Spinal Cord Injuries, Urinary Incontinence
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov